Biostage Inc logo

BSTG - Biostage Inc Share Price

$1.28 0.0  0.0%

Last Trade - 19/04/21

Micro Cap
Market Cap £8.59m
Enterprise Value £8.15m
Revenue £n/a
Position in Universe 6329th / 6849
Unlock BSTG Revenue
Relative Strength (%)
1m -15.4%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -67.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.12 0.082 0.000 0.000 0.000 0.000 46.0 -100.0%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, BiostageInc revenues was not reported. Net loss decreased 42% to$4.9M. Lower net loss reflects Research and developmentdecrease of 61% to $1.7M (expense), General andadministrative decrease of 16% to $2.4M (expense),Stock-based Compensation in SGA decrease of 26% to $833K(expense). Basic Earnings per Share excluding ExtraordinaryItems increased from -$1.21 to -$0.55.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


BSTG Revenue Unlock BSTG Revenue

Net Income

BSTG Net Income Unlock BSTG Revenue

Normalised EPS

BSTG Normalised EPS Unlock BSTG Revenue

PE Ratio Range

BSTG PE Ratio Range Unlock BSTG Revenue

Dividend Yield Range

BSTG Dividend Yield Range Unlock BSTG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BSTG EPS Forecasts Unlock BSTG Revenue
Profile Summary

Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe technology. Its Cellframe technology consists of a biocompatible scaffold that is seeded with the recipient's own cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, trachea or bronchus that are caused due to cancer, infection, trauma or congenital abnormalities. Its Cellframe technology is engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. Its Cellframe technology platform is used to create organ specific Cellspan implants. Its product candidates are in development and have not yet received regulatory approval for sale anywhere in the world.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated May 3, 2012
Public Since October 14, 2013
No. of Shareholders: 155
No. of Employees: 6
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Pink Sheets on Nasdaq
Shares in Issue 9,388,407
Free Float (0.0%)
Eligible for
× ISAs
BSTG Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BSTG
Upcoming Events for BSTG
Frequently Asked Questions for Biostage Inc
What is the Biostage Inc share price?

As of 19/04/21, shares in Biostage Inc are trading at $1.28, giving the company a market capitalisation of £8.59m. This share price information is delayed by 15 minutes.

How has the Biostage Inc share price performed this year?

Shares in Biostage Inc are currently trading at $1.28 and the price has moved by -60.62% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biostage Inc price has moved by -73.88% over the past year.

What are the analyst and broker recommendations for Biostage Inc?

Of the analysts with advisory recommendations for Biostage Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Biostage Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Biostage Inc next release its financial results?

Biostage Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Biostage Inc dividend yield?

Biostage Inc does not currently pay a dividend.

Does Biostage Inc pay a dividend?

Biostage Inc does not currently pay a dividend.

When does Biostage Inc next pay dividends?

Biostage Inc does not currently pay a dividend.

How do I buy Biostage Inc shares?

To buy shares in Biostage Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biostage Inc?

Shares in Biostage Inc are currently trading at $1.28, giving the company a market capitalisation of £8.59m.

Where are Biostage Inc shares listed? Where are Biostage Inc shares listed?

Here are the trading details for Biostage Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BSTG
What kind of share is Biostage Inc?

Based on an overall assessment of its quality, value and momentum, Biostage Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Biostage Inc share price forecast 2021?

We were not able to load any forecast data for Biostage Inc.

How can I tell whether the Biostage Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biostage Inc. Over the past six months, the relative strength of its shares against the market has been -23.31%. At the current price of $1.28, shares in Biostage Inc are trading at -27.23% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biostage Inc PE Ratio?

We were not able to find PE ratio data for Biostage Inc.

Who are the key directors of Biostage Inc?

Biostage Inc's management team is headed by:

David Green - DRC
Thomas Robinson - IND
Harout DerSimonian - CSO
Jason Jing Chen - CHM
James Shmerling - DRC
Hong Yu - PRE
Ting Li - DRC
Herman Sanchez - DRC
Peter Pellegrino - CFO
Who are the major shareholders of Biostage Inc?

Here are the top five shareholders of Biostage Inc based on the size of their shareholding:

DST Capital LLC Corporation
Percentage owned: 31.95% (3.00m shares)
Du (Xiaoyu) Individual Investor
Percentage owned: 7.99% (750k shares)
Zhou (Heping) Individual Investor
Percentage owned: 5.33% (500k shares)
Yu (Hong) Individual Investor
Percentage owned: 0.47% (44.5k shares)
Chen (Jing) Individual Investor
Percentage owned: 0.38% (36.0k shares)
Similar to BSTG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.